01 Jul 2025 Merchant Claimants Prevail in CAT’s Judgment on Multilateral Interchange Fees Financial Institutions & Products
19 Jun 2025 Safran obtains conditional approval for $1.8 billion acquisition of Collins Aerospace's flight control business Manufacturing
23 May 2025 Report on the EU Carbon Border Adjustment Mechanism: A review of the EU CBAM’s economic principles, expected impacts and outstanding issues Energy
Insights Healthcare & Life Sciences Search Search insight Filters Type Type… News Publications Services… Antitrust & Competition Antitrust & Competition: Mergers Antitrust & Competition: Conduct Antitrust & Competition: Damages Mergers & Acquisition Litigation Industries… Healthcare & Life Sciences Healthcare & Life Sciences Clear all Showing 1–4 of 4 results News • 08 Jan 2025 Leading IO and Health Care Economist Professor Matthew Grennan Affiliates with Compass Lexecon Article • 27 Aug 2024 GCR The Guide to Life Sciences: An Economist’s Perspective on Abuse of Dominance and Killer Acquisitions in the Pharma Industry Article • 05 Dec 2011 The Economic Benefits of Pharmacy Benefit Managers - J. Orszag & K. Green Article • 30 Oct 2002 Lexecon Economist Quoted in New York Times Article, Hospitals Battle For-Profit Groups for Patients
News • 08 Jan 2025 Leading IO and Health Care Economist Professor Matthew Grennan Affiliates with Compass Lexecon
Article • 27 Aug 2024 GCR The Guide to Life Sciences: An Economist’s Perspective on Abuse of Dominance and Killer Acquisitions in the Pharma Industry
Article • 30 Oct 2002 Lexecon Economist Quoted in New York Times Article, Hospitals Battle For-Profit Groups for Patients